Patients with melanoma with surgically removed cancer still have a high risk of disease recurrence. Intravenous pembrolizumab treatment improves recurrence-free and distant metastasis-free survival in patients with stage IIB or IIC melanoma, according to new research.

In this clinical trial, 976 patients were randomly assigned to receive pembrolizumab (n=487) or...